ESP | ENG

Efectos adversos: En pacientes tratados con fármacos anti-TNF

SAD
Biological agent
Infections
Horton
ETANERCEPT
4 infections (mild respir or ITU)
PAN
ETANERCEPT
Meningitis (cryptococo  sp)
Polimyositis
ETANERCEPT
recurent esophageal candidiasis
Polymyalgia R
ETANERCEPT
2 cystitis (ns) and 1 flu syndrome
Sarcoidosis
ETANERCEPT
cellulitis lower extremity
Sarcoidosis
ETANERCEPT
respiratory infections
Still
ETANERCEPT
Meningitis (lysteria)
Wegener
ETANERCEPT
infections (49); 8 zoster
Sjogren
ETANERCEPT
Parotiditis (ns)
Behçet
INFLIXIMAB
Flu-like
Behçet
INFLIXIMAB
Sinusitis
Behçet
INFLIXIMAB
Flu-like (6), TBC (1)
Behçet
INFLIXIMAB
Severe thoracic zoster
Behçet
INFLIXIMAB
respiratory infections
Behçet
INFLIXIMAB
1 case onset TBC; 1 herpetic keratitis plus otitis; 1 severe herpes; 1 recurrent ITU
Behçet
INFLIXIMAB
pulmonary TBC; pumonary legionella
Behçet
INFLIXIMAB
minor IRVA in 4
DM
INFLIXIMAB
cutaneous ulcer (MRSA + pseudomona) and pneumonia (MRSA)
DM
INFLIXIMAB
aspiration pneumonia and multi-organism bacteremia (Kb pneumoniae, S epidermidis, E coli, and S aureus)
Systemic sclerosis
INFLIXIMAB
peritonitis (candida albicans)
Horton
INFLIXIMAB
mild infections (17), zoster keratitis (1), bronchitis (1), infected hematoma (SA) and then pleunopneumonia (1)
SLE
INFLIXIMAB
ITU (E.coli in one, no specifi in 2)
Wegener + MPA
INFLIXIMAB
Pneumonia x 2 (H influenza) (1), recurr ITU (klebsiella) (1), leg cut abcess (MRSA) (1), endoftalmitis (nocardia) (1), broncopneumonia (ns) (1), skin ulcer (SA) + itu (E coli) (1), diarreic (ns) (1)
Policondritis
INFLIXIMAB
parasternal abcess (MRSA) and then multiple abcess and pneumonia
Polimiositis
INFLIXIMAB
pumonary (mycobacterium pellegrinum)
Sarcoidosis
INFLIXIMAB
TBC
Sarcoidosis
INFLIXIMAB
Oral candida (1)
Sarcoidosis
INFLIXIMAB
respiratory infections (31) (ns), pneumonia (6) (ns), other (17) (ns)